Stockhead TV
Check out the latest Cannabis news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
ECS Botanics jumps almost 5pc on $4.5 million Polish deal
Health & Biotech
RotoGro nabs deposit from Wolf Island to supply tech for new cannabis cultivation facility
Health & Biotech
Cymra secures cultivation permit as it builds a first-mover advantage in cannabis genetics
Health & Biotech
Medibis raises funds for research and cultivation facility, sets eyes on huge medicinal cannabis market
Health & Biotech
Creso Pharma welcomes Senate Democrats’ bid to legalise cannabis
Health & Biotech
Creso Pharma completes acquisition of Canada-based Halucenex, set to enter the US$100 billion psychedelic market
Health & Biotech
Creso Pharma expands global footprint to Netherlands with maiden sale of Red Light Holland
Health & Biotech
Cannabis stocks celebrate Pershing ownership change
Health & Biotech
ECS boosts executive team with four staff hires as it pursues a global cannabis growth strategy
Health & Biotech
Creso Pharma delivers another strong quarter as Connecticut brings a new market opportunity
Health & Biotech
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry
Health & Biotech
‘Massive’ opportunity in psychedelic-based therapy, expert says
Health & Biotech
Global pharma leader Vectura will help Incannex develop its concussion treatment drug
Health & Biotech
Creso Pharma is Canada-bound after announcing a merger with Red Light Holland
Health & Biotech
Weed Week: Amazon all-in on marijuana; free joints for jabs and Creso Pharma dual-listed in US
Health & Biotech
Why these 4 ASX cannabis stocks got investors’ attention today
Health & Biotech
Creso Pharma secures direct access to the world’s biggest cannabis market with successful US dual-listing
Health & Biotech
Creso Pharma’s takeover target expands scope of PTSD ‘shroom’ trial beyond military vets
Health & Biotech
Creso Pharma sells hemp products in Ecuador, gears up for the lucrative Latin American market
Health & Biotech
As medicinal cannabis rockets globally, here’s how Australia can become a production powerhouse
Health & Biotech
Weed Week: Major shifts in US legislation set to open the door for some ASX cannabis stocks
Health & Biotech
Creso Pharma about to enter California market after major legislation shift on psychedelics
Health & Biotech
Creso Pharma’s takeover target poised to enter lucrative US market
Health & Biotech
‘Tidal wave of demand’: There’s a pot shortage in New York
Health & Biotech
Creso Pharma expands into Eastern Europe with animal product launch in Poland
Health & Biotech
Shares in ECS Botanics get a boost following the launch of innovative wellness products
Health & Biotech
Creso Pharma launches hemp-based product for swine, enters the lucrative livestock market
Health & Biotech
US growing approvals a ‘monumental’ step away from Trump moratorium on pot licensing
Health & Biotech
Confusion and selloff as Credit Suisse pulls plug on US cannabis stocks
Health & Biotech
Incannex takes key step towards FDA approval for IHL-42X with new research partnership
Health & Biotech
Weed Week: Finally, a cannabis drug is on Australia’s Pharmaceutical Benefits Scheme
Health & Biotech
Phillip Morris mulls cannabis, pot market gets up off the couch… almost
Health & Biotech
Incannex highlights Q1 momentum with 4C update, shares rally again
Health & Biotech
US banks closer to legally doing business with cannabis, as ASX-listed Incannex pushes its way into the country
Health & Biotech
How Incannex is positioning to be the ‘next GW Pharma’, with CEO Joel Latham
Health & Biotech
Incannex gets more good news, as FDA approves expanded development pathway for its IHL-675 treatment
Health & Biotech
Canadian cannabis giants Aphria and Tilray closer to merger; ASX cannabis stock Bod snares new CFO
News
ASX Small Cap Lunch Wrap: Today’s high flyers and sinking ships
Health & Biotech
ECS Botanics flags major initiative to make Tasmania the ‘global epicentre’ of medical cannabis production
Health & Biotech
Biotech Avecho just got the all-clear for human cannabis trials
Health & Biotech
Virginia first southern US state to legalise cannabis, ASX-listed Medlab gets first nod from Europe patent office
Health & Biotech
Weed Week: Australian medical cannabis prescriptions are soaring
Health & Biotech
It looks like 2021 will be the Year of Cannabis Legalisation in the US
Energy
Asia could look to Australia for biofuels as region’s demand increases
Health & Biotech
NY finally on cannabis bandwagon, as ASX-listed Creso Pharma boosts coffers by $18 million
Health & Biotech
Cann Group, Emyria team up in bid to gain TGA approval for low-dose CBD gelcap
News
Rise and Shine: What you need to know before the ASX opens
Load More
